Skip to main content

Table 3 Publication status of included trials at 0, 2, and 3 years post-approval

From: Publication statuses of clinical trials supporting FDA-approved immune checkpoint inhibitors: a meta-epidemiological investigation

 

0 years

2 years

3 years

Publication status, n (%)

ICPi trials

Other anticancer drug trials

All trials

ICPi trials

Other anticancer drug trials

All trials

ICPi trials

Other anticancer drug trials

All trials

Full publication

6 (32)

35 (35)

41 (34)

11 (58)

68 (67)

79 (66)

15 (79)

71 (70)

86 (72)

Full report

0

10 (10)

10 (8)

2 (11)

12 (12)

14 (12)

2 (11)

11 (11)

13 (11)

Partial publication

5 (26)

5 (5)

10 (8)

5 (26)

6 (6)

11 (9)

2 (11)

7 (7)

9 (8)

Conference abstract

2 (11)

14 (14)

16 (13)

0

3 (3)

3 (3)

0

2 (2)

2 (2)

None

6 (32)

35 (35)

41 (34)

1 (5)

10 (10)

11 (9)

0

8 (8)

8 (7)

Unclear

0

2 (2)

2 (2)

0

2 (2)

2 (2)

0

2 (2)

2 (2)

  1. ICPi immune checkpoint inhibitor